Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Platelet Transfusion | 20 | 2016 | 314 | 4.390 |
Why?
|
Lymphopenia | 7 | 2023 | 285 | 3.200 |
Why?
|
Blood Transfusion | 13 | 2024 | 1301 | 2.890 |
Why?
|
Plateletpheresis | 8 | 2023 | 47 | 2.280 |
Why?
|
Blood Donors | 9 | 2023 | 355 | 2.040 |
Why?
|
Blood Platelets | 11 | 2023 | 2509 | 1.540 |
Why?
|
Blood Group Antigens | 6 | 2019 | 180 | 1.200 |
Why?
|
Blood Grouping and Crossmatching | 6 | 2020 | 108 | 1.160 |
Why?
|
Blood Banks | 4 | 2020 | 111 | 1.000 |
Why?
|
Hemorrhage | 11 | 2020 | 3461 | 0.940 |
Why?
|
ABO Blood-Group System | 9 | 2023 | 367 | 0.930 |
Why?
|
Bone Marrow Diseases | 1 | 2023 | 231 | 0.810 |
Why?
|
Blood Group Incompatibility | 4 | 2023 | 146 | 0.760 |
Why?
|
Thrombocytopenia | 8 | 2017 | 1178 | 0.750 |
Why?
|
Blood Safety | 2 | 2019 | 14 | 0.730 |
Why?
|
Erythrocytes | 11 | 2022 | 2455 | 0.720 |
Why?
|
False Positive Reactions | 1 | 2022 | 980 | 0.680 |
Why?
|
Platelet Count | 7 | 2019 | 780 | 0.670 |
Why?
|
Blood Preservation | 6 | 2015 | 177 | 0.620 |
Why?
|
Antibodies, Monoclonal | 8 | 2022 | 9274 | 0.600 |
Why?
|
Erythrocyte Transfusion | 8 | 2022 | 565 | 0.580 |
Why?
|
Medical Errors | 3 | 2021 | 1297 | 0.580 |
Why?
|
Pregnancy Complications, Hematologic | 2 | 2018 | 183 | 0.560 |
Why?
|
Safety | 1 | 2020 | 1186 | 0.530 |
Why?
|
Serologic Tests | 3 | 2017 | 374 | 0.530 |
Why?
|
Thrombotic Microangiopathies | 4 | 2017 | 132 | 0.500 |
Why?
|
Dithiothreitol | 3 | 2022 | 101 | 0.490 |
Why?
|
Plasma Exchange | 5 | 2020 | 152 | 0.490 |
Why?
|
Blood Component Removal | 2 | 2016 | 125 | 0.490 |
Why?
|
Antigens, Human Platelet | 3 | 2019 | 43 | 0.460 |
Why?
|
Rho(D) Immune Globulin | 1 | 2012 | 34 | 0.440 |
Why?
|
Angioedema | 1 | 2014 | 187 | 0.430 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 5 | 2020 | 131 | 0.430 |
Why?
|
Factor VIIa | 2 | 2012 | 101 | 0.420 |
Why?
|
Erythroblastosis, Fetal | 2 | 2017 | 60 | 0.420 |
Why?
|
Globins | 3 | 2003 | 416 | 0.400 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2013 | 142 | 0.390 |
Why?
|
Thrombocytopenia, Neonatal Alloimmune | 1 | 2011 | 20 | 0.390 |
Why?
|
Medical Records | 1 | 2015 | 1413 | 0.360 |
Why?
|
Postpartum Hemorrhage | 2 | 2013 | 258 | 0.350 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2019 | 4386 | 0.350 |
Why?
|
Alleles | 2 | 2019 | 6933 | 0.340 |
Why?
|
Desensitization, Immunologic | 1 | 2014 | 483 | 0.330 |
Why?
|
Military Medicine | 1 | 2011 | 176 | 0.330 |
Why?
|
Blood Specimen Collection | 2 | 2021 | 246 | 0.330 |
Why?
|
Wounds, Penetrating | 1 | 2011 | 307 | 0.320 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2016 | 1131 | 0.320 |
Why?
|
Leukocyte Reduction Procedures | 2 | 2020 | 15 | 0.320 |
Why?
|
Multiple Myeloma | 3 | 2022 | 5181 | 0.320 |
Why?
|
Humans | 94 | 2024 | 744366 | 0.310 |
Why?
|
HLA Antigens | 1 | 2012 | 1382 | 0.290 |
Why?
|
Antibodies | 3 | 2016 | 2460 | 0.290 |
Why?
|
Histocompatibility Testing | 2 | 2019 | 741 | 0.280 |
Why?
|
Pandemics | 3 | 2022 | 8385 | 0.270 |
Why?
|
Staphylococcus aureus | 1 | 2014 | 1453 | 0.270 |
Why?
|
Hematologic Diseases | 2 | 2023 | 498 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3135 | 0.260 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3242 | 0.260 |
Why?
|
Staphylococcal Infections | 1 | 2014 | 1400 | 0.250 |
Why?
|
Postoperative Hemorrhage | 3 | 2012 | 412 | 0.230 |
Why?
|
Neutrophils | 3 | 2023 | 3721 | 0.230 |
Why?
|
Rh-Hr Blood-Group System | 2 | 2018 | 65 | 0.220 |
Why?
|
Meningococcal Infections | 1 | 2023 | 77 | 0.220 |
Why?
|
Erythrocytes, Abnormal | 1 | 2023 | 125 | 0.220 |
Why?
|
Meningococcal Vaccines | 1 | 2023 | 95 | 0.220 |
Why?
|
Electronic Health Records | 2 | 2021 | 4468 | 0.220 |
Why?
|
Heparin | 2 | 2022 | 1637 | 0.210 |
Why?
|
Leukocyte Count | 2 | 2023 | 1588 | 0.210 |
Why?
|
Cold Temperature | 1 | 2005 | 772 | 0.200 |
Why?
|
Phosphoglycerate Kinase | 1 | 2001 | 68 | 0.200 |
Why?
|
Cardiac Surgical Procedures | 5 | 2015 | 3537 | 0.190 |
Why?
|
MNSs Blood-Group System | 1 | 2020 | 8 | 0.190 |
Why?
|
Sepsis | 1 | 2014 | 2593 | 0.180 |
Why?
|
Immunologic Factors | 2 | 2019 | 1580 | 0.170 |
Why?
|
Health Care Costs | 1 | 2013 | 3208 | 0.170 |
Why?
|
Saudi Arabia | 1 | 2020 | 209 | 0.170 |
Why?
|
Red-Cell Aplasia, Pure | 1 | 2018 | 30 | 0.170 |
Why?
|
Adult | 32 | 2022 | 214052 | 0.170 |
Why?
|
Chromosomes, Bacterial | 1 | 1999 | 282 | 0.160 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 2019 | 769 | 0.160 |
Why?
|
Donor Selection | 1 | 2020 | 201 | 0.160 |
Why?
|
Immunization, Passive | 1 | 2020 | 623 | 0.150 |
Why?
|
Neutropenia | 1 | 2023 | 895 | 0.150 |
Why?
|
Isoantibodies | 2 | 2023 | 679 | 0.150 |
Why?
|
Fetomaternal Transfusion | 1 | 2017 | 11 | 0.150 |
Why?
|
Middle Aged | 28 | 2023 | 213390 | 0.150 |
Why?
|
Periodicals as Topic | 2 | 2020 | 1431 | 0.150 |
Why?
|
Jehovah's Witnesses | 1 | 2015 | 13 | 0.130 |
Why?
|
Rabbits | 1 | 2022 | 4894 | 0.130 |
Why?
|
ADAM Proteins | 2 | 2015 | 243 | 0.130 |
Why?
|
Leukocytes | 1 | 2023 | 2045 | 0.130 |
Why?
|
Female | 35 | 2023 | 380193 | 0.130 |
Why?
|
Hypersensitivity | 2 | 2014 | 1102 | 0.130 |
Why?
|
Purpura, Thrombocytopenic, Idiopathic | 1 | 2019 | 233 | 0.130 |
Why?
|
Tachycardia, Sinus | 1 | 2014 | 42 | 0.120 |
Why?
|
HL-60 Cells | 1 | 2015 | 365 | 0.120 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2018 | 5445 | 0.120 |
Why?
|
Gene Transfer Techniques | 1 | 1999 | 1225 | 0.120 |
Why?
|
Health Planning Guidelines | 1 | 2015 | 163 | 0.120 |
Why?
|
Pregnancy | 9 | 2018 | 29144 | 0.120 |
Why?
|
Exons | 1 | 2020 | 2439 | 0.120 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2014 | 370 | 0.120 |
Why?
|
Vitrification | 1 | 2014 | 56 | 0.120 |
Why?
|
Thrombelastography | 2 | 2013 | 164 | 0.120 |
Why?
|
Intracranial Hemorrhage, Traumatic | 1 | 2014 | 54 | 0.120 |
Why?
|
Blood Platelet Disorders | 1 | 2014 | 58 | 0.120 |
Why?
|
History, 21st Century | 1 | 2020 | 1534 | 0.120 |
Why?
|
Aged | 21 | 2021 | 163288 | 0.120 |
Why?
|
Membrane Glycoproteins | 5 | 2017 | 3771 | 0.120 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 1680 | 0.110 |
Why?
|
Retrospective Studies | 14 | 2022 | 77460 | 0.110 |
Why?
|
Cross Reactions | 1 | 2015 | 841 | 0.110 |
Why?
|
Spinal Puncture | 1 | 2015 | 281 | 0.110 |
Why?
|
DNA | 2 | 2013 | 7294 | 0.110 |
Why?
|
Cardiopulmonary Bypass | 2 | 2015 | 1066 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1199 | 0.100 |
Why?
|
Gene Deletion | 1 | 2020 | 2751 | 0.100 |
Why?
|
Male | 30 | 2023 | 350115 | 0.100 |
Why?
|
Decision Support Systems, Clinical | 2 | 2014 | 1164 | 0.100 |
Why?
|
Coagulants | 1 | 2012 | 49 | 0.100 |
Why?
|
Models, Immunological | 1 | 2014 | 527 | 0.100 |
Why?
|
Pregnancy Trimester, Third | 1 | 2014 | 571 | 0.100 |
Why?
|
Utilization Review | 1 | 2013 | 392 | 0.100 |
Why?
|
Isoantigens | 1 | 2014 | 567 | 0.100 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2022 | 1354 | 0.100 |
Why?
|
Organizational Innovation | 1 | 2014 | 559 | 0.100 |
Why?
|
Genetic Vectors | 2 | 2003 | 3424 | 0.100 |
Why?
|
Equipment Design | 1 | 2019 | 3582 | 0.100 |
Why?
|
Hospitals, Military | 1 | 2011 | 67 | 0.100 |
Why?
|
Young Adult | 9 | 2020 | 56429 | 0.090 |
Why?
|
Organizational Culture | 1 | 2014 | 510 | 0.090 |
Why?
|
Consensus | 1 | 2019 | 2960 | 0.090 |
Why?
|
Cryopreservation | 1 | 2014 | 670 | 0.090 |
Why?
|
Cohort Studies | 7 | 2020 | 40559 | 0.090 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 501 | 0.090 |
Why?
|
Guideline Adherence | 3 | 2015 | 2265 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2460 | 0.080 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 855 | 0.080 |
Why?
|
Selection Bias | 1 | 2011 | 371 | 0.080 |
Why?
|
Gene Targeting | 2 | 2003 | 880 | 0.080 |
Why?
|
Myelodysplastic Syndromes | 1 | 2018 | 1352 | 0.080 |
Why?
|
Nanotechnology | 1 | 2014 | 710 | 0.080 |
Why?
|
Transfection | 3 | 2015 | 5895 | 0.080 |
Why?
|
Platelet-Rich Plasma | 1 | 2011 | 177 | 0.080 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2009 | 188 | 0.080 |
Why?
|
Infant, Newborn | 4 | 2014 | 25628 | 0.080 |
Why?
|
Societies, Medical | 1 | 2020 | 3743 | 0.080 |
Why?
|
Cost Savings | 1 | 2013 | 925 | 0.080 |
Why?
|
Platelet Aggregation | 1 | 2011 | 798 | 0.080 |
Why?
|
Kidney Transplantation | 1 | 2023 | 4251 | 0.080 |
Why?
|
Databases, Factual | 3 | 2021 | 7730 | 0.080 |
Why?
|
Refrigeration | 1 | 2007 | 29 | 0.070 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 25039 | 0.070 |
Why?
|
Autoimmune Diseases | 2 | 2016 | 2134 | 0.070 |
Why?
|
Recombination, Genetic | 2 | 2003 | 1586 | 0.070 |
Why?
|
Massachusetts | 1 | 2020 | 8662 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2001 | 7721 | 0.070 |
Why?
|
Fever | 1 | 2014 | 1616 | 0.070 |
Why?
|
Health Resources | 1 | 2013 | 911 | 0.070 |
Why?
|
Vitamin K Deficiency Bleeding | 1 | 2006 | 10 | 0.070 |
Why?
|
Vascular Surgical Procedures | 1 | 2015 | 1476 | 0.070 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15535 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2023 | 8949 | 0.070 |
Why?
|
Cell Shape | 2 | 2023 | 375 | 0.070 |
Why?
|
Child, Preschool | 5 | 2021 | 41005 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10183 | 0.070 |
Why?
|
Prognosis | 4 | 2023 | 29060 | 0.070 |
Why?
|
Galactose | 1 | 2007 | 306 | 0.070 |
Why?
|
Leadership | 1 | 2014 | 1357 | 0.060 |
Why?
|
Microbiological Techniques | 1 | 2006 | 102 | 0.060 |
Why?
|
Recombinant Proteins | 4 | 2012 | 6621 | 0.060 |
Why?
|
Practice Guidelines as Topic | 4 | 2015 | 7282 | 0.060 |
Why?
|
Logistic Models | 3 | 2016 | 13409 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2015 | 5974 | 0.060 |
Why?
|
Aged, 80 and over | 7 | 2021 | 57776 | 0.060 |
Why?
|
Infant | 3 | 2021 | 35134 | 0.060 |
Why?
|
Proportional Hazards Models | 4 | 2020 | 12356 | 0.060 |
Why?
|
Models, Biological | 3 | 2017 | 9584 | 0.060 |
Why?
|
Duffy Blood-Group System | 1 | 2023 | 58 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8642 | 0.060 |
Why?
|
Blood Coagulation | 1 | 2009 | 1127 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2019 | 15520 | 0.060 |
Why?
|
Treatment Failure | 1 | 2009 | 2618 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3611 | 0.050 |
Why?
|
Quality Improvement | 2 | 2015 | 3749 | 0.050 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2014 | 2026 | 0.050 |
Why?
|
Medical Staff, Hospital | 1 | 2007 | 601 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.050 |
Why?
|
Academic Medical Centers | 1 | 2013 | 2760 | 0.050 |
Why?
|
Aspirin | 1 | 2014 | 3283 | 0.050 |
Why?
|
Metalloendopeptidases | 1 | 2004 | 396 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2018 | 9955 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7658 | 0.050 |
Why?
|
Vaccines, Conjugate | 1 | 2023 | 333 | 0.050 |
Why?
|
Receptors, Virus | 2 | 1995 | 649 | 0.050 |
Why?
|
Child | 6 | 2021 | 77709 | 0.050 |
Why?
|
Partial Thromboplastin Time | 1 | 2022 | 206 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 3070 | 0.050 |
Why?
|
Antigens, CD | 4 | 1995 | 4026 | 0.050 |
Why?
|
Education, Medical, Continuing | 1 | 2007 | 840 | 0.050 |
Why?
|
Phagocytosis | 1 | 2007 | 1539 | 0.050 |
Why?
|
Incidence | 1 | 2019 | 20952 | 0.050 |
Why?
|
Clinical Trials as Topic | 2 | 2016 | 7914 | 0.050 |
Why?
|
Risk Factors | 4 | 2015 | 72296 | 0.050 |
Why?
|
Agglutination | 1 | 2020 | 43 | 0.050 |
Why?
|
Adolescent | 7 | 2021 | 85779 | 0.050 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2022 | 339 | 0.050 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 1999 | 118 | 0.040 |
Why?
|
Genomics | 1 | 2015 | 5717 | 0.040 |
Why?
|
Chronic Disease | 1 | 2014 | 9145 | 0.040 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 634 | 0.040 |
Why?
|
Transplantation, Homologous | 2 | 2018 | 4777 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2014 | 3524 | 0.040 |
Why?
|
Mutagenesis, Insertional | 1 | 2001 | 655 | 0.040 |
Why?
|
Medical Waste | 1 | 2018 | 14 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2020 | 793 | 0.040 |
Why?
|
Living Donors | 1 | 2023 | 621 | 0.040 |
Why?
|
Autoantibodies | 2 | 2017 | 2036 | 0.040 |
Why?
|
Hemostasis | 2 | 2012 | 458 | 0.040 |
Why?
|
United States | 5 | 2022 | 69872 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2001 | 1865 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1723 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10252 | 0.040 |
Why?
|
Hospitals | 2 | 2022 | 3954 | 0.040 |
Why?
|
Sweden | 1 | 2020 | 1341 | 0.040 |
Why?
|
Mycoses | 1 | 2020 | 376 | 0.040 |
Why?
|
Galactosyltransferases | 1 | 2018 | 264 | 0.040 |
Why?
|
Antibodies, Bacterial | 1 | 2023 | 1470 | 0.040 |
Why?
|
Animals | 7 | 2022 | 168768 | 0.040 |
Why?
|
Platelet Factor 4 | 1 | 2017 | 129 | 0.040 |
Why?
|
Physicians | 1 | 2015 | 4567 | 0.040 |
Why?
|
Factor V Deficiency | 1 | 1996 | 13 | 0.040 |
Why?
|
Genotype | 2 | 2023 | 12952 | 0.030 |
Why?
|
Multigene Family | 1 | 1999 | 1102 | 0.030 |
Why?
|
Methods | 1 | 2016 | 1129 | 0.030 |
Why?
|
Prospective Studies | 6 | 2023 | 53290 | 0.030 |
Why?
|
Reference Values | 1 | 2023 | 4982 | 0.030 |
Why?
|
Enterovirus B, Human | 1 | 1995 | 52 | 0.030 |
Why?
|
Complement Inactivator Proteins | 1 | 1995 | 79 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2021 | 867 | 0.030 |
Why?
|
Factor V | 1 | 1996 | 178 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2020 | 847 | 0.030 |
Why?
|
Wounds and Injuries | 2 | 2020 | 2400 | 0.030 |
Why?
|
Hematoma, Subdural | 1 | 1996 | 126 | 0.030 |
Why?
|
Cell Survival | 1 | 2005 | 5882 | 0.030 |
Why?
|
Hemoglobins | 1 | 2001 | 1532 | 0.030 |
Why?
|
Measles virus | 1 | 1995 | 68 | 0.030 |
Why?
|
Complement Factor H | 1 | 1995 | 110 | 0.030 |
Why?
|
Pilot Projects | 2 | 2021 | 8319 | 0.030 |
Why?
|
Amino Acids, Diamino | 1 | 2014 | 18 | 0.030 |
Why?
|
Early Diagnosis | 1 | 2020 | 1184 | 0.030 |
Why?
|
Anticoagulants | 2 | 2022 | 4600 | 0.030 |
Why?
|
Mortality | 2 | 2017 | 2864 | 0.030 |
Why?
|
Pregnancy Complications | 2 | 2006 | 2861 | 0.030 |
Why?
|
Ink | 1 | 2014 | 44 | 0.030 |
Why?
|
Receptors, Complement 3b | 1 | 2014 | 145 | 0.030 |
Why?
|
Decision Making, Organizational | 1 | 2014 | 139 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2015 | 426 | 0.030 |
Why?
|
Hemodilution | 1 | 2013 | 114 | 0.030 |
Why?
|
Quality Control | 1 | 2016 | 841 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2020 | 1782 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 11525 | 0.030 |
Why?
|
Erythrocyte Count | 1 | 2013 | 163 | 0.030 |
Why?
|
Intracellular Space | 1 | 2014 | 212 | 0.030 |
Why?
|
Tissue Donors | 1 | 2023 | 2241 | 0.030 |
Why?
|
Transplants | 1 | 2015 | 209 | 0.030 |
Why?
|
Total Quality Management | 1 | 2014 | 274 | 0.030 |
Why?
|
Complement C3 | 1 | 1995 | 461 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1584 | 0.030 |
Why?
|
Research | 1 | 2021 | 1999 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2016 | 1590 | 0.030 |
Why?
|
Multiple Organ Failure | 1 | 2015 | 389 | 0.030 |
Why?
|
Professional Practice | 1 | 2014 | 326 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2014 | 963 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1978 | 0.030 |
Why?
|
Bacterial Infections | 1 | 2020 | 1401 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2014 | 15297 | 0.030 |
Why?
|
Blood | 1 | 2014 | 598 | 0.030 |
Why?
|
Length of Stay | 2 | 2015 | 6311 | 0.030 |
Why?
|
DNA, Complementary | 1 | 1995 | 2050 | 0.030 |
Why?
|
Chest Tubes | 1 | 2012 | 150 | 0.030 |
Why?
|
RNA | 1 | 2001 | 2749 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1783 | 0.020 |
Why?
|
Bone Marrow | 1 | 2001 | 2948 | 0.020 |
Why?
|
Antibodies, Viral | 1 | 2022 | 3177 | 0.020 |
Why?
|
Treatment Outcome | 5 | 2019 | 63107 | 0.020 |
Why?
|
Stem Cells | 1 | 2003 | 3567 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3873 | 0.020 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2016 | 1366 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2021 | 2569 | 0.020 |
Why?
|
Oxygen | 1 | 2001 | 4189 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2015 | 15160 | 0.020 |
Why?
|
Nucleosomes | 1 | 2013 | 494 | 0.020 |
Why?
|
Propensity Score | 1 | 2016 | 1781 | 0.020 |
Why?
|
Acute Disease | 1 | 2020 | 7147 | 0.020 |
Why?
|
Inpatients | 1 | 2021 | 2518 | 0.020 |
Why?
|
Plasma | 2 | 2007 | 575 | 0.020 |
Why?
|
Blotting, Western | 2 | 2013 | 5181 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2019 | 6896 | 0.020 |
Why?
|
Program Development | 1 | 2015 | 1316 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2019 | 6539 | 0.020 |
Why?
|
CHO Cells | 3 | 1995 | 1409 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9688 | 0.020 |
Why?
|
Emergency Medical Services | 1 | 2020 | 1917 | 0.020 |
Why?
|
Leukemia | 1 | 2016 | 1510 | 0.020 |
Why?
|
Neoplasms | 2 | 2014 | 21696 | 0.020 |
Why?
|
Cricetinae | 3 | 1995 | 2475 | 0.020 |
Why?
|
Recurrence | 1 | 2019 | 8340 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1504 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 1999 | 9735 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 2014 | 2700 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39052 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2014 | 2076 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3519 | 0.020 |
Why?
|
Rh Isoimmunization | 1 | 2006 | 21 | 0.020 |
Why?
|
Medical Audit | 1 | 2007 | 467 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2014 | 2132 | 0.020 |
Why?
|
Mice | 3 | 2003 | 81201 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 19905 | 0.020 |
Why?
|
Genome, Human | 1 | 2018 | 4420 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15078 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3528 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 1996 | 4561 | 0.010 |
Why?
|
Glycosylation | 1 | 2007 | 1128 | 0.010 |
Why?
|
Phenotype | 2 | 2018 | 16367 | 0.010 |
Why?
|
Unnecessary Procedures | 1 | 2007 | 432 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2001 | 12073 | 0.010 |
Why?
|
Histones | 1 | 2013 | 2598 | 0.010 |
Why?
|
Medical Order Entry Systems | 1 | 2007 | 545 | 0.010 |
Why?
|
Survival Rate | 1 | 2015 | 12788 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10259 | 0.010 |
Why?
|
Sequence Deletion | 2 | 1995 | 1525 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2007 | 3144 | 0.010 |
Why?
|
Cells, Cultured | 2 | 2007 | 19233 | 0.010 |
Why?
|
Collagen | 1 | 2007 | 2688 | 0.010 |
Why?
|
Remission Induction | 1 | 2004 | 2385 | 0.010 |
Why?
|
Algorithms | 1 | 2018 | 13882 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18373 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2003 | 1701 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2007 | 5077 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2014 | 21748 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 2 | 1995 | 3773 | 0.010 |
Why?
|
Binding Sites | 2 | 1995 | 6111 | 0.010 |
Why?
|
Sulfur Radioisotopes | 1 | 1995 | 116 | 0.010 |
Why?
|
Foot Ulcer | 1 | 1996 | 59 | 0.010 |
Why?
|
Glycosylphosphatidylinositols | 1 | 1995 | 94 | 0.010 |
Why?
|
Plasmapheresis | 1 | 1996 | 211 | 0.010 |
Why?
|
Paraplegia | 1 | 1996 | 169 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1995 | 329 | 0.010 |
Why?
|
Pressure Ulcer | 1 | 1996 | 155 | 0.010 |
Why?
|
Phosphatidylinositols | 1 | 1995 | 291 | 0.010 |
Why?
|
Binding, Competitive | 1 | 1995 | 1157 | 0.010 |
Why?
|
Vincristine | 1 | 1996 | 1039 | 0.010 |
Why?
|
Epitope Mapping | 1 | 1994 | 311 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40075 | 0.010 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1995 | 798 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2004 | 3799 | 0.010 |
Why?
|
Macrophages | 1 | 2007 | 5660 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1995 | 1369 | 0.010 |
Why?
|
Prednisone | 1 | 1996 | 1574 | 0.010 |
Why?
|
Mutagenesis | 1 | 1995 | 1264 | 0.010 |
Why?
|
Cyclophosphamide | 1 | 1996 | 2242 | 0.010 |
Why?
|
DNA Primers | 1 | 1994 | 2891 | 0.010 |
Why?
|
Urinary Tract Infections | 1 | 1996 | 788 | 0.010 |
Why?
|
Kinetics | 1 | 1995 | 6476 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 13693 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1995 | 6171 | 0.000 |
Why?
|
Cell Membrane | 1 | 1995 | 3749 | 0.000 |
Why?
|
Polymorphism, Genetic | 1 | 1994 | 4328 | 0.000 |
Why?
|
Base Sequence | 1 | 1994 | 12797 | 0.000 |
Why?
|
Immunosuppressive Agents | 1 | 1996 | 4153 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1994 | 18111 | 0.000 |
Why?
|
Mutation | 1 | 1995 | 29786 | 0.000 |
Why?
|